yingbeiqi ceftazidime injection 1g per vial per box

Description

Indication & Scope

YingBeiQi® (Ceftazidime for Injection) is a prescription third-generation cephalosporin antibiotic indicated for the treatment of susceptible bacterial infections, including septicemia, hospital-acquired pneumonia, complicated urinary tract infections, intra-abdominal and biliary tract infections, severe skin and soft tissue infections, bone and joint infections, bacterial meningitis, and febrile neutropenia. It is particularly effective against Pseudomonas aeruginosa.

Mechanism: Ceftazidime inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), resulting in bacterial cell lysis and death.
Drug class: Third-generation cephalosporin antibiotic.
Clinical use: Treatment of serious Gram-negative bacterial infections, especially those caused by Pseudomonas aeruginosa, in hospitalized or immunocompromised patients.

Specification

Generic Name	Ceftazidime for Injection
Brand Name	YingBeiQi®
Ingredient	Ceftazidime
Dosage Form	Injection
Package	1 g/vial
Conditions Treated	Susceptible bacterial infections including septicemia, pneumonia, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, bone and joint infections, bacterial meningitis, and febrile neutropenia
Taboos	Hypersensitivity to ceftazidime, cephalosporins, or other β-lactam antibiotics
Place of origin	China
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store below 20°C in a dry place protected from light. Do not freeze.
Manufacturer	Qilu Pharmaceutical Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	H20013075
Approval Date	February 17, 2025
Shelf Life	24 months

How to use ?

Recommended Dose: Adults generally receive 1–2 g every 8–12 hours. Severe infections may require 2 g every 8 hours (maximum 6 g/day).

Time: Administer every 8–12 hours according to the severity of infection and renal function.

Instructions for use: Administer by deep intramuscular injection, slow intravenous injection, or intravenous infusion. Adjust the dose in patients with renal impairment.

Interaction: Use cautiously with aminoglycosides, loop diuretics, and anticoagulants due to increased risks of nephrotoxicity or bleeding.

Side effects: Injection-site reactions, diarrhea, nausea, rash, elevated liver enzymes, and hypersensitivity reactions.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is YingBeiQi® used for?

It is used to treat a wide range of serious bacterial infections, particularly those caused by susceptible Gram-negative bacteria, including Pseudomonas aeruginosa.

Is YingBeiQi® effective against Pseudomonas aeruginosa?

Yes. Ceftazidime is one of the most active third-generation cephalosporins against Pseudomonas aeruginosa.

How is YingBeiQi® administered?

It is administered by intramuscular injection or intravenous injection/infusion under the supervision of healthcare professionals.

Can patients with kidney impairment use YingBeiQi®?

Yes, but dosage adjustment is necessary according to renal function.